Skip to main content
Clinical Trials/NCT03862794
NCT03862794
Completed
Not Applicable

A Randomized Controlled Trial of Behaviourally Informed Feedback Letters Sent by the Chief Medical Officer on the Amount of Antibiotics and the Percentage of Broad Spectrum Antibiotics Prescribed in Primary Care

Public Health England1 site in 1 country7,000 target enrollmentNovember 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prescribing, Off-Label
Sponsor
Public Health England
Enrollment
7000
Locations
1
Primary Endpoint
total antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU) in November for each GP practice
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This trial aims to reduce unnecessary prescription of antibiotics and broad spectrum antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically the sample was GPs whose practices whose prescribed more than 1.161 items per STAR-PU or whose practices prescribed more that .965 items per STAR-PU and greater than 10% broad spectrum items. The intervention groups received a letter telling them they are among the highest prescribers of either their total or broad spectrum antibiotics, with a graph showing their prescribing compared to average prescribing ("their peers"). The letter also contained a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.

Registry
clinicaltrials.gov
Start Date
November 1, 2018
End Date
May 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • GP practices that prescribed more than 1.161 Antibacterial Items/STAR-PU for the twelve months (June 2017 - May 2018)
  • GP practices that prescribed more than 0.965 Antibacterial Items/STAR-PU and also more than 10% broad spectrum items for the twelve months (June 2017 - May 2018).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

total antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU) in November for each GP practice

Time Frame: 1 month

antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU)

total non-broad spectrum antibiotic prescribing weighted by STAR-PU in December for each GP practice

Time Frame: 2 months

percentage broad spectrum antibiotic prescribing in January for each GP practice

Time Frame: 3 months

total broad spectrum antibiotic prescribing weighted by STAR-PU in November for each GP practice

Time Frame: 1 month

broad spectrum antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU)

percentage broad spectrum antibiotic prescribing in November for each GP practice

Time Frame: 1 month

percentage broad spectrum antibiotic prescribing

total non-broad spectrum antibiotic prescribing weighted by STAR-PU in November for each GP practice

Time Frame: 1 month

total overall antibiotic prescribing minus total broad spectrum antibiotic prescribing

total antibiotic prescribing weighted by STAR-PU in December for each GP practice

Time Frame: 2 months

antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU)

total broad spectrum antibiotic prescribing weighted by STAR-PU in December for each GP practice

Time Frame: 2 months

percentage broad spectrum antibiotic prescribing in December for each GP practice

Time Frame: 2 months

total antibiotic prescribing weighted by STAR-PU in February for each GP practice

Time Frame: 4 months

total non-broad spectrum antibiotic prescribing weighted by STAR-PU in February for each GP practice

Time Frame: 4 months

total broad spectrum antibiotic prescribing weighted by STAR-PU in January for each GP practice

Time Frame: 3 months

total broad spectrum antibiotic prescribing weighted by STAR-PU in February for each GP practice

Time Frame: 4 months

percentage broad spectrum antibiotic prescribing in February for each GP practice

Time Frame: 4 months

total antibiotic prescribing weighted by STAR-PU in March for each GP practice

Time Frame: 5 months

total antibiotic prescribing in January weighted by STAR-PU for each GP practice

Time Frame: 3 months

total non-broad spectrum antibiotic prescribing weighted by STAR-PU in January for each GP practice

Time Frame: 3 months

total broad spectrum antibiotic prescribing weighted by STAR-PU in March for each GP practice

Time Frame: 5 months

percentage broad spectrum antibiotic prescribing in March for each GP practice

Time Frame: 5 months

total non-broad spectrum antibiotic prescribing weighted by STAR-PU in March for each GP practice

Time Frame: 5 months

total antibiotic prescribing weighted by STAR-PU in April for each GP practice

Time Frame: 6 months

total broad spectrum antibiotic prescribing weighted by STAR-PU in April for each GP practice

Time Frame: 6 months

total non-broad spectrum antibiotic prescribing weighted by STAR-PU in April for each GP practice

Time Frame: 6 months

percentage broad spectrum antibiotic prescribing in April for each GP practice

Time Frame: 6 months

Study Sites (1)

Loading locations...

Similar Trials